EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Implications of anti‐ganglioside antibodies in isolated dysphagia following COVID‐19 infection: Case series

Sejoon Kim, Jisun Bae, Geun-Young Park, Sun Im iD

Brain and Behavior · 2024

DOI: 10.1002/brb3.3514 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Brain and Behavior, 2024. Verfasst von Sejoon Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: COVID-19, Deglutition Disorders, Gangliosides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Health Industry Development Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There have been multiple reports about the occurrence of dysphagia after the contraction of coronavirus disease 2019 (COVID‐19). However, a detailed pathology and epidemiologic relation between COVID‐19 infection and dysphagia have yet to be established. Here, we report three cases of unexplained dysphagia after COVID‐19 diagnosis, with atypical clinical presentations. Case report All patients showed severe isolated lower cranial nerve involvement with dysphagia and aspiration, which required full tube feeding but showed no evidence of limb weakness or sensory symptoms. All tested positive for anti‐ganglioside antibody tests, which all commonly (GD1b, GM1, and GQ1b) are known to have terminal NeuNAc(α2‐3)Gal epitope.

Discussion

We report a series of cases featuring severe, isolated dysphagia post‐COVID‐19 infection, concomitant with positive anti‐ganglioside antibodies. One potential etiology is a variant of Guillain–Barré syndrome. Because only isolated dysphagia with sparing of the facial and extraocular muscles was evident in these cases, we explore the association between anti‐ganglioside antibodies specific to NeuNAc(α2‐3)Gal, which has been frequently associated with the development of bulbar dysfunction. Given that NeuNAc(α2‐3)Gal exhibits an affinity for the spike glycoprotein of SARS‐CoV‐2, a cross‐reaction against NeuNAc(α2‐3)Gal may possibly contribute to isolated dysphagia following COVID‐19 infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Deglutition DisordersGangliosidesAgedFemaleHumansMaleAutoantibodiesGuillain-Barre SyndromeSARS-CoV-2Aged, 80 and over

Stichwörter der Autor:innen

COVID‐19DysphagiaSARS‐CoV‐2anti‐ganglioside antibody

Substanzen

AutoantibodiesGangliosides

Autor:innen und Institutionen

  • Department of Rehabilitation Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Department of Rehabilitation Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

ORCID-Profile: Sun Im

Förderung

  • Korea Health Industry Development Institute

Zitieren

APA

Kim, S., Bae, J., Park, G. Y., & Im, S. (2024). Implications of anti‐ganglioside antibodies in isolated dysphagia following COVID‐19 infection: Case series. Brain and Behavior. https://doi.org/10.1002/brb3.3514

Vancouver

Kim S, Bae J, Park GY, Im S. Implications of anti‐ganglioside antibodies in isolated dysphagia following COVID‐19 infection: Case series. Brain and Behavior. 2024. doi:10.1002/brb3.3514

BibTeX
@article{Kim2024,
  author = {Kim, Sejoon and Bae, Jisun and Park, Geun-Young and Im, Sun},
  title = {Implications of anti‐ganglioside antibodies in isolated dysphagia following COVID‐19 infection: Case series},
  journal = {Brain and Behavior},
  year = {2024},
  doi = {10.1002/brb3.3514}
}
Kostenlos starten →